Galapagos NV
GLPG
#5080
Rank
โ‚ฌ1.62 B
Marketcap
24,24ย โ‚ฌ
Share price
0.00%
Change (1 day)
-0.05%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: โ‚ฌ1.62 Billion

As of July 2026 Galapagos NV has a market cap of โ‚ฌ1.62 Billion. This makes Galapagos NV the world's 5080th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.62 B-12.13%
2025โ‚ฌ1.85 B7.18%
2024โ‚ฌ1.72 B-28.66%
2023โ‚ฌ2.42 B-11.04%
2022โ‚ฌ2.72 B-15.56%
2021โ‚ฌ3.22 B-38.72%
2020โ‚ฌ5.26 B-56.35%
2019โ‚ฌ12.05 B174.87%
2018โ‚ฌ4.38 B9.61%
2017โ‚ฌ4.00 B41.28%
2016โ‚ฌ2.83 B25.66%
2015โ‚ฌ2.25 B380.44%
2014โ‚ฌ0.46 B3.4%
2013โ‚ฌ0.45 B6.23%
2012โ‚ฌ0.42 B55.55%
2011โ‚ฌ0.27 B-14.13%
2010โ‚ฌ0.31 B79.77%
2009โ‚ฌ0.17 B142.03%
2008โ‚ฌ73.5 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ553.53 B 33,900.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ145.26 B 8,822.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ403.23 B 24,667.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ90.31 B 5,447.63%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ279.73 B 17,082.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ264.57 B 16,151.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ93.95 B 5,670.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
โ‚ฌ88.28 M-94.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ35.26 B 2,065.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel